Logo image
The long non-coding RNA GHSROS reprograms prostate cancer cell lines toward a more aggressive phenotype
Journal article   Open access   Peer reviewed

The long non-coding RNA GHSROS reprograms prostate cancer cell lines toward a more aggressive phenotype

P.B. Thomas, P. Jeffery, M.D. Gahete, E. Whiteside, C. Walpole, M. Maugham, L. Jovanovic, J. Gunter, E. Williams, C. Nelson, …
PeerJ, Vol.9, Art. e10280
2021
pdf
RNAGHSROS.pdfDownloadView
Published (Version of Record) Open Access
url
Free to Read *No subscription requiredView

Abstract

It is now appreciated that long non-coding RNAs (lncRNAs) are important players in orchestrating cancer progression. In this study we characterized GHSROS, a human lncRNA gene on the opposite DNA strand (antisense) to the ghrelin receptor gene, in prostate cancer. The lncRNA was upregulated by prostate tumors from different clinical datasets. Transcriptome data revealed that GHSROS alters the expression of cancer-associated genes. Functional analyses in vitro showed that GHSROS mediates tumor growth, migration and survival, and resistance to the cytotoxic drug docetaxel. Increased cellular proliferation of GHSROS-overexpressing PC3, DU145, and LNCaP prostate cancer cell lines in vitro was recapitulated in a subcutaneous xenograft model. Conversely, in vitro antisense oligonucleotide inhibition of the lncRNA reciprocally regulated cell growth and migration, and gene expression. Notably, GHSROS modulates the expression of PPP2R2C, the loss of which may drive androgen receptor pathway-independent prostate tumor progression in a subset of prostate cancers. Collectively, our findings suggest that GHSROS can reprogram prostate cancer cells toward a more aggressive phenotype and that this lncRNA may represent a potential therapeutic target.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

73 File views/ downloads
72 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.147 Prostate Cancer
1.147.859 Androgen Receptor
Web Of Science research areas
Oncology
ESI research areas
Multidisciplinary
Logo image